NASDAQ:TRUPTrupanion Stock Price, Forecast & News

Trupanion's stock was trading at $26.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TRUP shares have increased by 64.7% and is now trading at $42.89. View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Trupanion.

Trupanion is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Trupanion.

Trupanion Inc (NASDAQ:TRUP) released its quarterly earnings results on Thursday, April, 30th. The financial services provider reported ($0.03) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.04) by $0.01. The financial services provider earned $111.30 million during the quarter, compared to analysts' expectations of $110.10 million. Trupanion had a negative return on equity of 1.23% and a negative net margin of 0.40%. The firm's quarterly revenue was up 28.0% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.04) earnings per share. View Trupanion's earnings history.

8 Wall Street analysts have issued 12-month target prices for Trupanion's stock. Their forecasts range from $20.00 to $50.00. On average, they anticipate Trupanion's share price to reach $38.57 in the next year. This suggests that the stock has a possible downside of 10.1%. View analysts' price targets for Trupanion.

Media headlines about TRUP stock have been trending negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Trupanion earned a news sentiment score of -2.2 on InfoTrie's scale. They also assigned media stories about the financial services provider a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the next several days. View the latest news about Trupanion.

Trupanion saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 8,700,000 shares, a drop of 7.1% from the June 15th total of 9,360,000 shares. Based on an average daily trading volume, of 371,800 shares, the days-to-cover ratio is presently 23.4 days. Approximately 30.3% of the shares of the company are short sold. View Trupanion's Current Options Chain.

Some companies that are related to Trupanion include UnitedHealth Group (UNH), Cigna (CI), Anthem (ANTM), Humana (HUM), Centene (CNC), Molina Healthcare (MOH) and Advanzeon Solutions (CHCR). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), McEwen Mining (MUX), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Baidu (BIDU), Gilead Sciences (GILD), Starbucks (SBUX) and Splunk (SPLK).

Trupanion trades on the NASDAQ under the ticker symbol "TRUP."

Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TRUP stock can currently be purchased for approximately $42.89.

Trupanion has a market capitalization of $1.51 billion and generates $383.94 million in revenue each year. The financial services provider earns $-1,810,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Trupanion employs 586 workers across the globe.

The official website for Trupanion is www.trupanion.com.

Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at 855-727-9079 or via email at [email protected]